Resminostat Uses, Dosage, Side Effects and more
Resminostat has been used in trials studying the treatment of Sezary Syndrome, Mycosis fungoides, Hodgkin's Lymphoma, Hepatocellular Carcinoma, and Lymphoma, T-Cell, Cutaneous, among others.
| Trade Name | Resminostat |
| Generic | Resminostat |
| Resminostat Other Names | Resminostat |
| Type | |
| Formula | C16H19N3O4S |
| Weight | Average: 349.41 Monoisotopic: 349.109627278 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
